Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination-Reference-Cited by-同舟云学术

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination

Published:2023-01-10 Issue:1 Volume:7 Page:174-177
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Valsecchi Carla¹^ORCID,Gualtierotti Roberta¹²^ORCID,Arcudi Sara²^ORCID,Ciavarella Alessandro¹³^ORCID,Schiavone Lucia¹^ORCID,Novembrino Cristina¹^ORCID,Siboni Simona Maria¹^ORCID,Mannucci Pier Mannuccio¹^ORCID,Peyvandi Flora¹²^ORCID

Affiliation:

1. 1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

2. 2Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy

3. 3Università degli Studi di Milano, Department of Biomedical Sciences for Health, Milan, Italy

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/1/174/2028806/blooda_adv-2022-008989-main.pdf

Reference21 articles.

1. The past and future of haemophilia: diagnosis, treatments, and its complications;Peyvandi;Lancet,2016

2. Hemophilia therapy: the future has begun;Mannucci;Haematologica,2020

3. An update of the current pharmacotherapeutic armamentarium for hemophilia;Mahlangu;A. Expert Opin Pharmacother,2022

4. Factor VIII replacement is still the standard of care in haemophilia A;Aledort;Blood Transfus,2019

5. PEGylation, successful approach to drug delivery;Veronese;Drug Discov Today,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A;Blood Advances;2024-05-30

2. Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII;Journal of Thrombosis and Haemostasis;2023-10

3. Cases of less‐than‐expected FVIII activity in previously treated patients during post‐marketing surveillance of N8‐GP;Haemophilia;2023-09-20

4. Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII;Journal of Thrombosis and Haemostasis;2023-06

5. Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution;Molecular Therapy - Methods & Clinical Development;2023-06